Cocoș Daiana-Ionela, Dumitrescu Eugenia, Muselin Florin, Brezovan Diana, Degi János, Boldura Oana-Maria, Cristina Romeo T
Department of Pharmacy and Pharmacology, University of Life Science "King Michael I", 300645 Timisoara, Romania.
Department of Toxicology, University of Life Science "King Michael I", 300645 Timisoara, Romania.
Antibiotics (Basel). 2025 Sep 8;14(9):905. doi: 10.3390/antibiotics14090905.
Wild birds are increasingly recognized as reservoirs and vectors of antimicrobial-resistant (AMR) , but comprehensive assessments across Europe remain limited. AMR represents a growing threat to global health under the One Health framework. This review aimed to evaluate the occurrence, diversity, and resistance patterns of in wild birds across Europe (1969-2025), and to identify ecological and methodological trends. Following Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 guidelines, we searched PubMed and Web of Science until July 2025. Inclusion criteria targeted studies reporting isolation and/or AMR in free-living European birds. Data were synthesized thematically by bacterial species, avian order, resistance profile, and country. Risk of bias was assessed based on sampling, reporting, and diagnostic clarity. Eighty studies met the inclusion criteria, covering over 18,000 wild birds from 25 countries. and were most reported, often exhibiting resistance to β-lactams, fluoroquinolones, and tetracyclines. AMR was detected in birds from both urban and natural areas. Study designs varied widely, with inconsistent methods for bacterial identification and susceptibility testing. Wild birds in Europe carry resistant , including strains with clinically relevant resistance profiles. These findings support their inclusion in One Health AMR surveillance and highlight the need for harmonized protocols, expanded molecular tools, and ecological integration.
野生鸟类日益被视为抗菌药物耐药性(AMR)的宿主和传播媒介,但欧洲范围内的全面评估仍然有限。在“同一个健康”框架下,AMR对全球健康构成的威胁日益增大。本综述旨在评估1969年至2025年欧洲野生鸟类中AMR的发生情况、多样性和耐药模式,并确定生态和方法学趋势。按照系统评价和Meta分析的首选报告项目(PRISMA)2020指南,我们检索了截至2025年7月的PubMed和科学网。纳入标准针对报告在自由生活的欧洲鸟类中分离出细菌和/或AMR的研究。数据按细菌种类、鸟类目、耐药谱和国家进行主题综合。基于抽样、报告和诊断清晰度评估偏倚风险。80项研究符合纳入标准,涵盖来自25个国家的18000多只野生鸟类。大肠杆菌和金黄色葡萄球菌的报告最多,它们通常对β-内酰胺类、氟喹诺酮类和四环素类药物耐药。在城市和自然区域的鸟类中均检测到了AMR。研究设计差异很大,细菌鉴定和药敏试验方法不一致。欧洲的野生鸟类携带耐药菌,包括具有临床相关耐药谱的菌株。这些发现支持将它们纳入“同一个健康”AMR监测,并强调需要统一方案、扩展分子工具和进行生态整合。